sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
As of
24 Nov 2009
1,332.90INR
Rs1,332.90
24 Nov 2009
+0.06%
Rs1,332.10
Rs1,339.85
11,929
Rs1,370.00
Rs1,327.00
Rs1,380.00
Rs525.00
0.51
13,538
News
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Gupta, Desh |
Chairman of the Board |
66,720,000 |
| Gupta, Nilesh |
Group President, Executive Director |
-- |
| Gupta, Vinita |
Group President & CEO of Lupin Pharmaceuticals Inc., USA, Non-Executive Director |
-- |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
Rs114,788.60 |
| Shares Outstanding (Mil.) |
86.17 |
| Float (Mil.) |
44.20 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend (Rs INR) |
12.50 |
| Payout Ratio(TTM) % |
18.03 |
| |
| Financial Strength |
| Quick Ratio |
1.04 |
| Current Ratio |
-- |
| LT Debt/Equity |
-- |
| Total Debt/Equity |
-- |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
19.66 |
| Price/Sales(TTM) |
2.65 |
| Price/Book(TTM) |
-- |
| Price/Cash Flow(TTM) |
16.75 |
| |
|
| Per Share Data |
| Earnings(TTM) |
Rs68.68 |
| Sales(TTM) |
Rs511.08 |
| Book Value(MRQ) |
Rs-- |
| Cash Flow(TTM) |
Rs80.91 |
| Cash(MRQ) |
Rs-- |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-- |
| Return on Assets(TTM) |
-- |
| Return on Investment(TTM) |
-- |
| |
|
| Margins |
| Gross Margin(TTM) % |
29.25 |
| Operating Margin(TTM) % |
15.74 |
| Profit Margin(TTM) % |
13.62 |
|
| |
|